Cytochalasin C

Cytochalasin C
Product Name Cytochalasin C
CAS No.: 22144-76-9
Catalog No.: CFN70315
Molecular Formula: C30H37NO6
Molecular Weight: 507.6 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Targets: NAD(P)H oxidase
Source: The seed culture of solid wheat.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
Cytochalasin C inhibits phytomitogen-induced human lymphocyte proliferation. Cytochalasin C can activate both NAD(P)H oxidase and selective degranulation of neutrophils incubated in salt-restricted media and that differential inhibition of these two processes by monovalent cations and/or anions is produced at some step(s) subsequent to cytochalasin interaction with the cell.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Molecules.2019, 24(12):E2286
  • Korean J. Medicinal Crop Sci.2022, 30(2):124-133
  • Front Pharmacol.2018, 9:236
  • Mol Divers.2022, s11030-022-10586-3.
  • Front Pharmacol.2020, 11:566490.
  • Biochem Pharmacol. 2020, 177:114014.
  • Korean Herb. Med. Inf.2020, 8(2):233-242.
  • Anticancer Res.2014, 34(7):3505-9
  • Nutrients.2021, 13(10):3414.
  • Food Funct.2022, doi: 10.1039
  • RA VII

    Catalog No: CFN92604
    CAS No: 86229-97-2
    Price: Inquiry(manager@chemfaces.com)
    RA-V

    Catalog No: CFN92605
    CAS No: 64725-24-2
    Price: Inquiry(manager@chemfaces.com)
    RA-XI

    Catalog No: CFN92606
    CAS No: 143277-27-4
    Price: Inquiry(manager@chemfaces.com)
    Enniatin B

    Catalog No: CFN97902
    CAS No: 917-13-5
    Price: Inquiry(manager@chemfaces.com)
    Enniatin B1

    Catalog No: CFN97986
    CAS No: 19914-20-6
    Price: Inquiry(manager@chemfaces.com)
    Methylpheophorbide A

    Catalog No: CFN91976
    CAS No: 5594-30-9
    Price: Inquiry(manager@chemfaces.com)
    Cytochalasin D

    Catalog No: CFN98204
    CAS No: 22144-77-0
    Price: Inquiry(manager@chemfaces.com)
    Cytochalasin C

    Catalog No: CFN70315
    CAS No: 22144-76-9
    Price: Inquiry(manager@chemfaces.com)
    Cytochalasin B

    Catalog No: CFN96781
    CAS No: 14930-96-2
    Price: Inquiry(manager@chemfaces.com)
    Biochimica Et Biophysica Acta General Subjects, 1981, 678(2):238-244.
    Activation of superoxide production and differential exocytosis in polymorphonuclear leukocytes by cytochalasins A, B, C, D and E: Effects of various ions.[Reference: WebLink]
    All of the common cytochalasins activate superoxide anion release and exocytosis of beta-N-acetylglucosaminidase and lysozyme from guinea-pig polymorphonuclear leukocytes (neutrophils) incubated in a buffered sucrose medium.
    METHODS AND RESULTS:
    Half-maximal activation of both processes is produced by approx. 0.2 microM cytochalasin A, Cytochalasin C greater than 2 microM cytochalasin B greater than or equal to 4-5 microM cytochalasin D, cytochalasin E. While maximal rates of O2- release and extents of exocytosis require extracellular calcium (1-2 mM), replacing sucrose with monovalent cation chlorides is inhibitory to neutrophil activation by cytochalasins. Na , K or choline inhibit either cytochalasin B- or E-stimulated O2- production with IC50 values of 5-10 mM and inhibition occurs whether Cl-, NO3- or SCN- is the anion added with Na or K . Release of beta-N-acetylglucosaminidase in control or cytochalasin B-stimulated cells is inhibited by NaCl(IC50 approximately 10 mM), while cytochalasin E-stimulated exocytosis is reduced less and K or choline chloride are ineffective in inhibiting either cytochalasin B- or E-stimulated exocytosis. Release of beta-glucuronidase, myeloperoxidase or acid phosphatase from neutrophils incubated in buffered sucrose is not stimulated by cytochalasin B. Stimulation of either O2- or beta-N-acetylglucosaminidase release by low concentrations of cytochalasin A is followed by inhibition of each at higher concentrations.
    CONCLUSIONS:
    It appears that all cytochalasins can activate both NAD(P)H oxidase and selective degranulation of neutrophils incubated in salt-restricted media and that differential inhibition of these two processes by monovalent cations and/or anions is produced at some step(s) subsequent to cytochalasin interaction with the cell.
    Journal of biological chemistry, 1981, 256(3):1290.
    The effects of cytochalasins on lymphocytes. Identification of distinct cytochalasin-binding sites in relation to mitogenic response and hexose transport.[Reference: WebLink]

    METHODS AND RESULTS:
    Cytochalasin B inhibits phytomitogen-induced human lymphocyte proliferation with a Ki of approximately 6 X 10(-6) M. Cytochalasin A, Cytochalasin C, Cytochalasin D, Cytochalasin E, and Cytochalasin H are also inhibitory with varying degrees of potency, whereas cytochalasin G and chaetoglobosins A, B, C, E, F, and J are not at concentrations as high as 15 microM. Cytochalasin B also competitively inhibits carrier-mediated equilibrium exchange of hexose (Ki of approximately 7 X 10(-7) M), but cytochalasin E is ineffective. Cytochalasin B binds reversibly to the lymphocyte at three distinct sites: L, M, and H. The ligand binding at L site shows the apparent dissociation constant (Kd) of 1 to 3 X 10(-6) M and total binding sites (Bt) of 6 to 8 X 10(7)/cell, represents approximately 85% of the total saturable binding, displays a broad specificity interacting with Cytochalasin C, cytochalasin D, and cytochalasin E, is not displaceable by D-glucose, is located mostly in a cytosol fraction, and exists in intimate relation to cytoskeletal actin. M site shows a Kd of 2 to 4 X 10(-7) M and Bt of 5 to 8 X 10(6)/cell, represents about 8% of the total saturable binding, shows stringent specificity not being displaced by Cytochalasin C, cytochalasin D, and cytochalasin E, is competitively displaced by D-glucose and phloretin, and is quantitatively recoverable in the plasma membrane fraction. The binding to H site shows a Kd of 0.5 to 1.0 X 10(-7) M and Bt of 4 to 5 X 10(6)/cell, representing approximately 7% of the total saturable binding, shows a broad specificity, is insensitive to D-glucose, and is membrane bound.
    CONCLUSIONS:
    It is proposed that L site is actin and is involved in the inhibition of lymphocyte mitogenesis, whereas M site is associated with the hexose transport carrier. Structure-activity relationships of cytochalasin effects are also discussed.
    7-(4-hydroxy-3-methoxyphenyl)-1-phenylhept-4-en-3-one (DPHB)

    Catalog No: CFN95139
    CAS No: 79559-60-7
    Price: $268/20mg
    Leachianol F

    Catalog No: CFN95147
    CAS No: 164123-50-6
    Price: $318/5mg
    Licoflavanone

    Catalog No: CFN95213
    CAS No: 119240-82-3
    Price: $413/5mg
    Deoxy euphorbia factor L1

    Catalog No: CFN95340
    CAS No: 247099-01-0
    Price: $318/10mg
    Murracarpin

    Catalog No: CFN95409
    CAS No: 120786-76-7
    Price: $413/5mg
    Bergamjuicin

    Catalog No: CFN95422
    CAS No: 2376307-20-7
    Price: $318/5mg
    2',4'-Dihydroxychalcone

    Catalog No: CFN95493
    CAS No: 1776-30-3
    Price: $318/20mg
    Butesuperin B-7''-O-beta-glucopyranoside

    Catalog No: CFN95502
    CAS No: N/A
    Price: $413/5mg
    Regaloside I

    Catalog No: CFN95525
    CAS No: 126239-78-9
    Price: $318/5mg
    Calleryanin

    Catalog No: CFN95556
    CAS No: 20300-53-2
    Price: $318/5mg